Jacobs Levy Equity Management
ANAC

Jacobs Levy Equity Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Jacobs Levy Equity Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-7,330
Closed -$392K – 1333
2016
Q1 		$392K Buy
+7,330
New +$541K 0.01% 794

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Jacobs Levy Equity Management's ANAC Position: Q2 2016 in Review

Jacobs Levy Equity Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 7,330 shares — an estimated $392K sold.

Jacobs Levy Equity Management first reported a position in ANAC in Q1 2016 and held it in 1 quarter. The position peaked at $392K in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Jacobs Levy Equity Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 7,330 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $392K.
  • Jacobs Levy Equity Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2016 and held it in 1 quarter.
  • Jacobs Levy Equity Management's ANACOR PHARMACEUTICALS INC COM position peaked at $392K in Q1 2016.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2016, filed 15 Aug 2016.